Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
April 20, 2017
FIRST INSTALLATION OF THE WORLD’S MOST RESPONSIVE SMART-TINTING GLASS UNVEILED IN SAN FRANCISCO
April 12, 2017
MILLENDO THERAPEUTICS APPOINTS MARY LYNNE HEDLEY, PH.D. AND CAROLE NUECHTERLEIN, J.D. TO BOARD OF DIRECTORS
April 12, 2017
NOHLA THERAPEUTICS ANNOUNCES COLLABORATION WITH UNIVERSITY OF CALIFORNIA, DAVIS TO OPTIMIZE MANUFACTURING PROCESS AND SUPPLY CELL THERAPY PRODUCT FOR CLINICAL TRIALS
April 5, 2017
SPYRYX BIOSCIENCES PRESENTS DATA AND CORPORATE UPDATE AT TWO RECENT CONFERENCES IN SUPPORT OF CLINICAL CANDIDATE FOR CYSTIC FIBROSIS
April 4, 2017
CARB-X INJECTS UP TO $48 MILLION TO ACCELERATE FIRST POWERED BY CARB-X PORTFOLIO OF DRUG DISCOVERY AND DEVELOPMENT PROJECTS TO TACKLE ANTIBIOTIC RESISTANCE
April 4, 2017
HOMOLOGY MEDICINES APPOINTS BRAD SMITH AS CHIEF FINANCIAL OFFICER
April 3, 2017
AUDENTES THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR AT132 TO TREAT X-LINKED MYOTUBULAR MYOPATHY
March 27, 2017
RENNOVIA ENTERS PILOTING STAGE OF ITS KEY BIO-BASED HDO PLATFORM
March 22, 2017
APREA THERAPEUTICS ANNOUNCES RESEARCH COLLABORATION WITH MEMORIAL SLOAN KETTERING CANCER CENTER
March 20, 2017
AUDENTES THERAPEUTICS ANNOUNCES PRESENTATION OF DATA FROM RECENSUS, A MEDICAL CHART REVIEW OF PATIENTS WITH X-LINKED MYOTUBULAR MYOPATHY (XLMTM)
« Previous Page
1
…
4
5
6
7
8
Next Page »